PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 30.9 CHF -2.37% Market Closed
Market Cap: 1B CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

Net Margin
PolyPeptide Group AG

-8.7%
Current
-1%
Average
-0.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-8.7%
=
Net Income
-28.6m
/
Revenue
327.3m

Net Margin Across Competitors

Country CH
Market Cap 1B CHF
Net Margin
-9%
Country US
Market Cap 1.4T USD
Net Margin
9%
Country US
Market Cap 211.1B USD
Net Margin
14%
Country US
Market Cap 177.9B USD
Net Margin
18%
Country KR
Market Cap 71.2T KRW
Net Margin
24%
Country CH
Market Cap 39.5B CHF
Net Margin
9%
Country US
Market Cap 39.9B USD
Net Margin
9%
Country US
Market Cap 39.4B USD
Net Margin
22%
Country US
Market Cap 28.1B USD
Net Margin
21%
Country US
Market Cap 24B USD
Net Margin
-36%
Country US
Market Cap 23.7B USD
Net Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for PolyPeptide Group AG.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-8.7%
=
Net Income
-28.6m
/
Revenue
327.3m
What is the Net Margin of PolyPeptide Group AG?

Based on PolyPeptide Group AG's most recent financial statements, the company has Net Margin of -8.7%.